DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $35,003,000 | -15.7% | 1,736,277 | +56.1% | 0.01% | 0.0% |
| Q2 2021 | $41,504,000 | +89.5% | 1,112,089 | +29.8% | 0.01% | +66.7% |
| Q1 2021 | $21,905,000 | +1704.4% | 856,610 | +1454.6% | 0.00% | – |
| Q4 2020 | $1,214,000 | +492.2% | 55,101 | +384.8% | 0.00% | – |
| Q3 2020 | $205,000 | -75.4% | 11,365 | -65.3% | 0.00% | – |
| Q2 2020 | $833,000 | +56.9% | 32,784 | +13.5% | 0.00% | – |
| Q1 2020 | $531,000 | -84.1% | 28,891 | -81.0% | 0.00% | -100.0% |
| Q4 2019 | $3,345,000 | +1112.0% | 151,835 | +688.1% | 0.00% | – |
| Q3 2019 | $276,000 | -30.8% | 19,267 | -23.9% | 0.00% | – |
| Q2 2019 | $399,000 | +35.3% | 25,331 | +25.5% | 0.00% | – |
| Q1 2019 | $295,000 | -70.4% | 20,182 | -78.3% | 0.00% | – |
| Q4 2018 | $995,000 | -16.5% | 93,004 | +19.2% | 0.00% | – |
| Q3 2018 | $1,191,000 | -1.7% | 78,015 | -21.1% | 0.00% | – |
| Q2 2018 | $1,211,000 | +783.9% | 98,872 | +588.4% | 0.00% | – |
| Q1 2018 | $137,000 | +705.9% | 14,362 | +666.4% | 0.00% | – |
| Q4 2017 | $17,000 | +142.9% | 1,874 | +57.6% | 0.00% | – |
| Q3 2017 | $7,000 | +75.0% | 1,189 | -4.6% | 0.00% | – |
| Q2 2017 | $4,000 | -97.7% | 1,246 | -97.6% | 0.00% | – |
| Q1 2017 | $176,000 | -17.0% | 51,538 | -29.9% | 0.00% | – |
| Q4 2016 | $212,000 | -2.8% | 73,488 | +97.6% | 0.00% | – |
| Q3 2016 | $218,000 | +77.2% | 37,184 | -9.2% | 0.00% | – |
| Q2 2016 | $123,000 | +61.8% | 40,957 | +191.8% | 0.00% | – |
| Q1 2016 | $76,000 | -95.6% | 14,038 | -90.3% | 0.00% | -100.0% |
| Q4 2015 | $1,721,000 | -20.5% | 144,934 | -45.1% | 0.00% | 0.0% |
| Q3 2015 | $2,166,000 | +1270.9% | 263,807 | +2230.9% | 0.00% | – |
| Q2 2015 | $158,000 | -4.8% | 11,318 | +63.6% | 0.00% | – |
| Q1 2015 | $166,000 | -8.8% | 6,918 | -37.5% | 0.00% | – |
| Q4 2014 | $182,000 | -70.9% | 11,064 | -77.5% | 0.00% | – |
| Q3 2014 | $625,000 | +228.9% | 49,100 | +481.8% | 0.00% | – |
| Q2 2014 | $190,000 | -73.1% | 8,439 | -66.3% | 0.00% | – |
| Q1 2014 | $707,000 | – | 25,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|